Gene- and stem cell-based therapeutics for cartilage regeneration and repair
- PMID: 25884598
- PMCID: PMC4397817
- DOI: 10.1186/s13287-015-0058-5
Gene- and stem cell-based therapeutics for cartilage regeneration and repair
Abstract
Cell-based regeneration of damaged or diseased articular cartilage still faces significant clinical challenge due to inadequate environmental regulation of stem cell proliferation and chondrogenic differentiation. The role of insulin-like growth factor in critical steps of human bone marrow-derived mesenchymal stem cell chondrogenesis has potential in optimizing the therapeutic use of mesenchymal stem cells in cartilage disorders. In addition to the previously described benefits of recombinant adeno-associated viral vector for in vivo gene therapy, demonstrated by Frisch and colleagues, such vector is also a safe and efficient delivery system for the genetic modification of human bone marrow-derived mesenchymal stem cells via ex vivo insulin-like growth factor 1 gene transfer, so that implanted mesenchymal stem cells continuously release a therapeutic level of insulin-like growth factor 1 to achieve sustained mesenchymal stem cell chondrogenesis for cartilage regeneration.
Comment on
-
Influence of insulin-like growth factor I overexpression via recombinant adeno-associated vector gene transfer upon the biological activities and differentiation potential of human bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2014 Aug 27;5(4):103. doi: 10.1186/scrt491. Stem Cell Res Ther. 2014. PMID: 25163769 Free PMC article.
References
-
- Frisch J, Venkatesan JK, Rey-Rico A, Schmitt G, Madry H, Cucchiarini M. Influence of insulin-like growth factor I overexpression via recombinant adeno-associated vector gene transfer upon the biological activities and differentiation potential of human bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2014;5:103. doi: 10.1186/scrt491. - DOI - PMC - PubMed
-
- Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, et al. Tissue engineering for articular cartilage repair - the state of the art. Eur Cell Mater. 2013;25:248–67. - PubMed
-
- Miller RE, Grodzinsky AJ, Cummings K, Plaas AH, Cole AA, Lee RT, et al. Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum. 2010;62:3686–94. doi: 10.1002/art.27709. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources